Streetbeat News

Stock Prices

PESI

Perma-Fix Envirn Servs (NASDAQ:PESI) is set to release its latest quarterly earnings report on November 2, 2023. Analysts estimate an earnings per share (EPS) of $0.10. The company's past performance shows a mixed trend of beating and missing EPS estimates. The company's shares were trading at $9.3 as of October 31, with a 120.75% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 01, 2023 | 8:02 pm

GECC

Great Elm Capital (NASDAQ:GECC) is set to release its latest quarterly earnings report on November 2, 2023. Analysts estimate an earnings per share (EPS) of $0.44. The company's past performance shows it beat EPS estimates last quarter, leading to a 7.3% increase in share price. However, the stock has seen a 12.29% decrease over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 01, 2023 | 8:02 pm

SAMG

Silvercrest Asset Mgmt Gr (NASDAQ:SAMG) is set to release its latest quarterly earnings report on November 2, 2023. Analysts estimate an earnings per share (EPS) of $0.38. The company's past performance shows a mixed trend of beating and missing EPS estimates, which has led to varied stock price changes. The company's shares were trading at $17.75 as of October 31, with a 52-week return of -1.44%.

Portfolio Pulse from Benzinga Insights

November 01, 2023 | 8:01 pm

BZFD

BuzzFeed (NASDAQ:BZFD) is set to release its quarterly earnings report on November 2, 2023. Analysts estimate an earnings per share (EPS) of $-0.08. The company's past performance shows a trend of missing EPS estimates, which has led to significant drops in share price. Shares of BuzzFeed were trading at $0.32 as of October 31, with a 52-week decline of 83.16%.

Portfolio Pulse from Benzinga Insights

November 01, 2023 | 8:01 pm

KPTI

Karyopharm Therapeutics (NASDAQ:KPTI) is set to release its latest quarterly earnings report on November 2, 2023. Analysts estimate an earnings per share (EPS) of $-0.28. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $0.87, down 82.3% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 01, 2023 | 8:01 pm

CRDF

Cardiff Oncology (NASDAQ:CRDF) is set to release its latest quarterly earnings report on November 2, 2023. Analysts estimate an earnings per share (EPS) of $-0.28. The company's stock performance has been generally negative over the last 52-week period, with shares down 24.65%. Last quarter, the company beat EPS by $0.02, resulting in an 8.38% increase in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 01, 2023 | 8:01 pm

CRIS

Curis (NASDAQ:CRIS) is set to release its quarterly earnings report on November 2, 2023. Analysts estimate an EPS of $-2.33. The company's past performance shows a trend of missing EPS estimates and subsequent share price drops. The stock is currently trading at $4.73, down 71.44% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 01, 2023 | 8:01 pm

JD

A large investor has taken a bearish stance on JD.com (NASDAQ:JD), with 11 uncommon options trades spotted, split between 45% bullish and 54% bearish. The overall sentiment of these big-money traders is bearish, with 6 puts and 5 calls. The whales have been targeting a price range from $20.0 to $60.0 for JD.com over the last 3 months. The price of JD is down -0.35% at $25.33. JP Morgan, Goldman Sachs, Benchmark, and Barclays maintain their ratings on JD.com, while Bernstein downgraded its action to Market Perform.

Portfolio Pulse from Benzinga Insights

November 01, 2023 | 8:01 pm

TTSH

Tile Shop Holdings (NASDAQ:TTSH) is set to release its latest quarterly earnings report on November 2, 2023. Analysts estimate an earnings per share (EPS) of $0.05. The company's past performance shows a trend of beating EPS estimates, which has typically resulted in a share price increase. The company's shares were trading at $5.49 as of October 31, with a 52-week increase of 21.84%.

Portfolio Pulse from Benzinga Insights

November 01, 2023 | 8:01 pm

REGN

A significant amount of unusual options activity has been observed for Regeneron Pharmaceuticals (NASDAQ:REGN), with a predominantly bearish stance. Of the detected trades, 80% were bearish and 20% bullish. The total amount for puts was $346,389 and for calls was $261,957. Whales have been targeting a price range from $770.0 to $835.0 for REGN over the last 3 months. The current price of REGN is up 1.52% at $791.76. Morgan Stanley, Cantor Fitzgerald, and RBC Capital have maintained their ratings on REGN with price targets of $915, $850, and $847 respectively.

Portfolio Pulse from Benzinga Insights

November 01, 2023 | 8:01 pm